| Literature DB >> 30261582 |
Grzegorz Józef Nowicki1, Barbara Ślusarska2, Agnieszka Bartoszek3, Katarzyna Kocka4, Alina Deluga5, Hanna Kachaniuk6, Marta Łuczyk7.
Abstract
Due to its devastating consequences, late-life depression is an important public health problem. The aim of the study was an analysis of variables which may potentially influence the risk of depression (GDS-SF). Furthermore, the aim was to study possible mediating effects of given variables on the relationship between the total protein concentration and the risk of depression in older adults with chronic diseases, and physical function impairment. The research sample included 132 older adults with chronic conditions and physical function impairments, residing in a long-term care in residential environment. In the studied group of sensory organs, diseases proved to be a significant moderator of the relationship between GDS-SF and total serum protein concentration. A stronger relationship was observed in subjects suffering from diseases of sensory organs (b = -6.42, 95% CI= -11.27; -1.58). The Barthel index and 25(OH)D vitamin were the most significant mediators of the examined relationship. Cohort research is suggested to confirm the hypothesis.Entities:
Keywords: depression; elderly people; long-term care; physical function; total protein
Mesh:
Substances:
Year: 2018 PMID: 30261582 PMCID: PMC6213179 DOI: 10.3390/nu10101374
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Model presenting the examined mediation effect. X, independent variable (protein concentration); M, mediator; Y, dependent variable (GDS-SF); a, association between X and M; b, association between M and Y after controlling for X; c`, direct effects.
Characteristics of the examined group.
| Variable | |
|---|---|
| Medical interview | |
| Under long-term care (years) | 3.91 ± 2.61 a |
| Result on the Barthel index | 43.20 ± 27.06 a |
| Result on GDS-SF scale | 7.34 ± 3.10 a |
| Amount of medicinal substances taken | 7.9 ± 2.8 a |
| Comorbidities | |
| Respiratory system | 19 (14.4) b |
| Endocrine system | 54 (40.9) b |
| Nervous system | 35 (26.5) b |
| Sensory | 12 (9.1) b |
| Psychiatric | 55 (41.7) b |
| Rheumatic | 77 (58.3) b |
| Laboratory test results | |
| Total protein (g/dL) | 7.09(6.61–7.37) c |
| 25(OH)D vitamin(ng/mL) | 14.41 (8.64–26.63) c |
| B12 vitamin (pg/mL) | 390.76 ± 143.35 a |
| Folic acid (ng/mL) | 5.4 (3.74–9.92) c |
| Total cholesterol (mg/dL) | 183 (158.0–218.0) c |
| HDL Cholesterol (mg/dL) | 53.55 (42.62–64.22) c |
| LDL Cholesterol(mg/dL) | 106.5 (86.0–130.75) c |
| Triglycerides (mg/dL) | 115 (88.25–158.75) c |
| Anthropometric variables | |
| Calf circumference (cm) | 36.05 ± 5.42 a |
| Mid-upper arm circumference(cm) | 30.79 ± 7.90 a |
| Tibial bone length (cm) | 48.02 ± 5.44 a |
| Thickness of the skinfold under the shoulder (cm) | 2.6 (2.1–4.0) c |
| Skinfold of arm muscle triceps (cm) | 2.3 (2.0–3.8) c |
Data are presented as: a, mean ± SD; b, n (%); c, median (Q1–Q3).
Analysis of the linear regression of the depression risk (GDS-SF) determinant in the examined group.
| Variable | b | 95% CI |
|---|---|---|
| Gender | ||
| Male | 0.40 | (−0.89; 1.70) |
| Age | 0.02 | (−0.04; 0.09) |
| Marital status | ||
| In a relationship | −0.86 | (−1.97; 0.24) |
| Cohabitant | ||
| None | 0.75 | (−0.54; 2.03) |
| Medical interview | ||
| Under long-term healthcare (years) | −0.04 | (−0.26; 0.17) |
| Results in the Barthel index | −0.02 | (−0.04; −0.004) * |
| Amount of medicinal substances taken | 0.004 | (−0.36; 0.36) |
| Comorbidities: | ||
| Respiratory system | −1.45 | (−2.95; 0.06) |
| Endocrine system | −0.33 | (−1.42; 0.76) |
| Nervous system | 0.23 | (−0.98; 1.44) |
| Sensory | −0.36 | (−2.22; 1.50) |
| Psychiatric | −0.35 | (−1.42; 0.72) |
| Rheumatic | 0.51 | (−0.58; 1.60) |
| Laboratory tests results | ||
| Total protein | −1.10 | (−2.08; −0.13) * |
| 25(OH)D Vitamin | −0.008 | (−0.02; 0.007) |
| B12 Vitamin | −0.001 | (−0.004; 0.003) |
| Folic acid | 0.001 | (−0.05; 0.06) |
| Total cholesterol | −0.004 | (−0.01; 0.007) |
| HDL Cholesterol | −0.03 | (−0.07; −0.002) * |
| LDL Cholesterol | 0.001 | (−0.01; 0.01) |
| Triglycerides | −0.001 | (−0.01; 0.009) |
| Anthropometric variables | ||
| Calf circumference | −0.08 | (−0.18; 0.02) |
| Mid-upper arm circumference | −0.079 | (−0.15; −0.01) * |
| Tibia bone length from foot base to the knee | −0.003 | (−0.10; 0.10) |
| Thickness of under the shoulder skinfold | 0.05 | (−0.007; 0.12) |
| Skinfold of arm triceps muscle | 0.06 | (−0.008; 0.12) |
b, coefficient from linear regression. Statistical significance is indicated by * p < 0.05.
Moderation effect tested for the correlation between depression and protein concentration.
| Model | Moderator Coefficient | Protein Coefficient | Interaction Coefficient | F |
|---|---|---|---|---|
| Gender | ||||
| R2 = 0.04 | 2.28 (−13.40; 17.96) | −0.77 (−3.75; 2.21) | 0.27 (−2.50; 1.97) | 1.81 |
| ΔR2 = 0.0004 | 0.42 (−0.86; 1.69) | −1.11 (−2.09; −0.13) | 2.71 | |
| Age | ||||
| R2 = 0.037 | 0.06 (−56.86; 77.60) | −0.44 (-9.94; 9.06) | −0.008 (−0.12; 0.11) | 1.66 |
| ΔR2 = 0.0001 | 0.0002 (−0.065; 0.065) | −1.1 (−2.15; −0.056) | 2.49 | |
| Comorbidities | ||||
| Respiratory system | ||||
| R2 = 0.06 | −0.67 (−18.78; 17.43) | −0.89 (−5.73; 3.95) | −0.10 (−2.69; 2.48) | 2.86 |
| ΔR2 = 0.000 | −1.41 (−2.89; 0.08) | −1.09 (−2.005; 0.12) * | 4.33 | |
| Endocrine system | ||||
| R2 = 0.05 | −8.34 (−22.14; 5.46) | −2.84 (−5.97; 0.28) | 1.17 (−0.80; 3.14) | 2.16 |
| ΔR2 = 0.01 | −0.18 (-1.26; 0.90) | −1.08 (−2.07; −0.10) | 2.55 | |
| Nervous system | ||||
| R2 = 0.04 | 6.86 (−9.29; 23.01) | 0.51 (−3.72; 4.73) | −0.93 (−3.26; 1.39) | 2.01 |
| ΔR2 = 0.005 | 0.39 (−0.81; 1.59) | −1.14 (−2.13; −0.16) * | 2.71 | |
| Sensory | ||||
| R2 = 0.075 | −39.7 (−74.85; −4.55) | −11.95 (−21.69; −2.21) * | 5.52 (0.58; 10.47) * | 3.44 |
| ΔR2 = 0.035 * | −0.49 (−2.33; 1.35) | −1.12 (−2.10; −0.14) * | 2.64 | |
| Psychiatric | ||||
| R2 = 0.043 | 0.09 (−13.69; 13.87) | −1.04 (−4.33; 2.24) | −0.05(−2.01; 1.92) | 1.89 |
| ΔR2 = 0.000 | −0.24 (−1.29; 0.82) | −1.12 (−2.08; -0.16) * | 2.86 | |
| Rheumatic | ||||
| R2 = 0.046 | 1.59 (−12.31; 15.49) | −0.93 (−3.92; 2.07) | −0.14 (−2.12; 1.83) | 2.05 |
| ΔR2 = 0.0002 | 0.58 (−0.49; 1.64) | −1.13 (−2.11; −0.16) * | 3.08 | |
R2, coefficient of determination; ΔR2, increase R2 due to interaction; F, test static from model. Statistical significance is indicated by * p < 0.05.
Figure 2The relationship between GDS-SF and total protein concentration among subjects with and without diseases of sensory organs.
Mediation effect tested for correlation between depression and protein concentration.
| Mediator (M) A | Direct Effect (Path c’) B | Indirect Effect (a*b) | ||||
|---|---|---|---|---|---|---|
| b | 95% CI | b | 95% CI | b | 95% CI | |
| Laboratory parameters: | ||||||
| 25 (OH)D vitamin | −0.05 | (−0.10; −0.007) * | −0.786 | (−1.78; 0.21) | −0.162 | (−0.45; −0.01) * |
| B12 vitamin | −0.0003 | (−0.004; 0.003) | −1.09 | (−2.12; −0.06) * | −0.012 | (−0.31; 0.13) |
| Folic acid | 0.045 | (−0.05; 0.14) | −1.135 | (−2.12; −0.15) | 0.032 | (−0.04; 0.23) |
| Total Cholesterol | −0.003 | (−0.01; 0.007) | −1.078 | (−2.06; −0.09) * | −0.027 | (−0.25; 0.04) |
| HDL Cholesterol | −0.027 | (−0.06; 0.006) | −0.908 | (−1.91; −0.09) * | −0.197 | (−0.63; 0.01) |
| LDL Cholesterol | 0.0004 | (−0.13; 0.014) | −1.10 | (−2.08; −0.12) * | −0.0013 | (−0.13; 0.09) |
| Triglycerides | 0.001 | (−0.008; 0.01) | −1.132 | (−2.13; −0.13) * | 0.027 | (−0.12; 0.30) |
| Result on the Barthel index | −0.02 | (−0.04; −0.0002) * | −0.882 | (−1.87; 0.11) | −0.223 | (−0.54; −0.05) * |
| Anthropometric variables: | ||||||
| Calf circumference | −0.073 | (−0.17; 0.02) | −1.039 | (−2.01; −0.07) * | −0.035 | (−0.35; 0.07) |
| Mid-upper arm circumference | −0.141 | (−0.25; −0.035) * | −0.900 | (−1.86; 0.06) | −0.174 | (−0.50; 0.02) |
| Tibia bone length from foot base to the knee | −0.011 | (−0.11; 0.09) | −1.082 | (−2.06; −0.10) * | 0.008 | (−0.12; 0.24) |
| Thickness of under the shoulder skinfold | 0.05 | (−0.01; 0.11) | −1.014 | (−1.99; −0.04) * | −0.059 | (−0.50; 0.06) |
| Arm triceps muscle skinfold | 0.05 | (−0.01; 0.12) | −1.014 | (−1.99; −0.04) * | −0.600 | (−0.47; 0.07) |
b, coefficient from linear regression; A, association between mediator and GDS-SF after controlling for total protein concentration; B, association between total protein concentration and GDS-SF after controlling for moderator; statistical significance is indicated by * p < 0.05.